scispace - formally typeset
J

John B. Imboden

Researcher at University of California, San Francisco

Publications -  111
Citations -  8376

John B. Imboden is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: T cell & Jurkat cells. The author has an hindex of 48, co-authored 111 publications receiving 8089 citations. Previous affiliations of John B. Imboden include Johns Hopkins University School of Medicine & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores.

TL;DR: Data indicate that, during activation, perturbation of the T3-antigen receptor complex generates inositol trisphosphate, which functions as an intracellular signal to release Ca2+ from intrACEllular stores, leading to increases in [Ca2+]i.
Journal ArticleDOI

The Role of the T3/Antigen Receptor Complex in T-Cell Activation

TL;DR: The role of the T3/antigen receptor complex is summarized by the diagram presented, and for those events occurring after the early events pictured in Figure 4 that result in gene activation, the sequence is a black box.
Journal ArticleDOI

Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium

TL;DR: The results suggest that T3 and/or associated molecules participate in T-cell activation through mechanisms that lead to increases in [Ca2+]i and that their expression is a relative requirement for T- cell activation by PHA.
Book ChapterDOI

Cell surface molecules and early events involved in human T lymphocyte activation.

TL;DR: The physiologic activation of human T cells by antigen involves events that occur between ligands and receptors at the interface of the T cell and antigen-presenting cell (or target cell).
Journal ArticleDOI

CD28 ligation in T-cell activation: evidence for two signal transduction pathways.

TL;DR: Evidence is presented that the degree of aggregation of CD28 on the cell surface regulates two distinct CD28-associated signals, and CD28 aggregation appears to trigger a phospholipase C activation pathway that differs from the CD3/TCR-linked pathway.